Pharmaceuticals

EcoSupp listens, learns, and delivers

Or Biba is the founder and VP of business development at EcoSupp.
A patient at a Maccabi Health Center in Jerusalem receives a vaccination against the 'H1N1' swine flu. Israeli health authorities has started vaccinating the population against swine flu. December 20, 2009.

Israeli health officials call for sanctions on anti-vaxxers as flu morbidity rate rises

Automated pharmaceutical conveyor line, robotic arms handling medical vials

Israel's biotech moment: How science, data, and geopolitics are converging - opinion

The entrance of the former German Nazi concentration camp in Dachau near Munich, Germany.

From Auschwitz to Dachau: How a pharmacist became central to Nazi camp medical crimes - study


Pharmaceutical residuals found polluting marine life on Israel's coasts

Unlike other pollutants, pharmaceuticals, which are not fully metabolized in the body, are designed to affect biological systems in even very small amounts.

Prof. Noa Shenkar sampling ascidians.

Health Ministry hides results from satisfactory service survey

The Health Ministry regularly distributes results following surveys regarding its external partners.

THE HEALTH Ministry office in Jerusalem is one location where adults can receive the MMR vaccine.

In light of coronavirus crisis, resilience is crucial, says Takeda GM

Arie Kramer spoke to 'The Jerusalem Post' about the role of Big Pharma in a health crisis, the importance of meriting people’s trust and what they are doing to help.

Arie Kramer, general manager Takeda Israel.

Hillel's Tech Corner: CytoReason: Where AI meets drug development

CytoReason’s technology uses a machine learning model to build a molecular level understanding of tissues in diseases on the cellular level.

CytoReason.

Moderna, Pfizer start pivotal COVID-19 vaccine trials, eye year-end launch

The study is expected to include about 120 sites globally and could include up to 30,000 participants. It will include regions heavily impacted by COVID-19.

A researcher at the University of Pittsburgh works on a COVID-19 vaccine candidate, a fingertip-sized patch with dissolvable microscopic needles, in Pittsburgh, Pennsylvania, U.S.

Pfizer, BioNTech say vaccine expected to be ready for approval by December

If it receives marketing approval, the companies are preparing to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the end of 2021.

Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration

BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial

"These first trial results show that the vaccine yields immune activity and causes a strong immune response," said BioNTech's co-founder and Chief Executive Officer Ugur Sahin.

Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration

Canadian company Medicago develops plant-based coronavirus vaccine

The company has developed a unique method of creating a vaccine by letting plants do the work. "We're using plants as mini factories," said Natalie Charland, a senior director at Medicago.

tobacco plant 224.88

Bayer to test new drugs on 3D-printed heart tissue at Tel Aviv University

The new method of testing bypasses many tedious screening methods, making it faster, cheaper and more efficient.

A 3D printed, small-scaled human heart engineered from the patient’s own materials and cells.

The Lounge March 10, 2020: SuperPharm

A number of Super Pharm’s managers attended the ceremony, and Kupler and Keshet arranged to meet again in the future to discuss continued cooperation.

FROM LEFT, Raz Rahav, Chris Kannan and Shay Habib.